CHI Releases Pre-Registrant List for its 4th Integrated R&D Informatics & Knowledge Management Event

Jan. 3, 2012 - PRLog -- CHI’s fourth annual Integrated R&D Informatics & Knowledge Management: Leveraging Data from Disparate Sources to Create Value conference will bring together thought leaders from across the life sciences to share their experiences dealing with moving large and complex data sets through public and private networks, the integration of disperse data streams  and the correlation between pre-clinical observations and clinical outcomes.

Pre-registered delegates (partial list):

Abbott Labs   
Senior Group Leader

American Medical Association   
Director, Clinical Informatics

Arizona State University   
Professor

AstraZeneca Pharmaceuticals Inc   
Sr. Dir R&D Information

Atrium Research & Consulting   
CEO

BioFortis Inc.   
Director, Marketing

Biogen Idec Inc.   
Assoc Dir R&D Information Technology

Broad Institute   
CIO

Carmot Therapeutics Inc.   
President

Collaborative Drug Discovery Inc.
President & CEO

Collaborative Drug Discovery Inc.   
Director, Operations

Complete Genomics Inc   
Associate Product Manager

Complete Genomics Inc.   
CMO

Dolcera   
CEO

Drexel University   
Associate Professor

Duke University   
Project Leader

E Merge Tech Global Svcs Pvt Ltd   
CEO

Eli Lilly & Co.   
Research Advisor

Eli Lilly & Co.   
Sr Dir LRL IT Research

Ezose Sciences   
VP R&D

F Hoffmann La Roche Inc.
Global Head

Genentech Inc.
Director, Computational Chemistry & Cheminformatics

Genentech Inc.
Statistical Programmer Analyst

Genentech Inc   
Sr. Manager

GGA Software Svcs LLC   
Dir Market Dev

Gilead Sciences Inc.   
Sr. IT Specialist

IDBS   
VP Translational Research

Ingenuity Systems Inc.
Assoc Staff

Ingenuity Systems Inc.
Sr. Manager

Johnson & Johnson Pharmaceutical R&D   
Program Manager

Johnson & Johnson Pharmaceutical R&D   
Sr. Research Fellow & Head

LHASA Ltd   
CEO

LIMSource   
Publisher

LOreal   
Head Bioinformatics Platform

MedImmune   
Assoc Director Clinical Informatics

MedImmune Ltd   
Research Scientist

Merck   
Principal Scientist

Merck & Co.   
Exec Dir Discovery & Preclinical IT

Millennium: The Takeda Oncology Co.   
Lead Software Engineer

Novartis Institutes for BioMedical Research Inc.   
Global Leader, Novartis Data Federation Initiative

Novartis Vaccines & Diagnostics Inc.   
Assoc Director

One World Health   
Director

Partners HealthCare System Inc.   
Asst Prof Neurology

Pfizer Global R&D   
Sr Dir Research BT

Pfizer Global R&D Groton Labs   
Assoc Research Fellow

Pfizer Inc.   
Principle Scientist

PointCross Life Sciences   
VP

RemedyMD   
Chairman & CEO

revelytix   
VP & Dir Ontology Engineering Services

Roche   
Sr. Statistical Analyst

Spry   
Sr. Information Architect

Stanford University   
Visting Scholar

Tessella Inc.   
Global Account Dir

University of Miami   
Research Asst Prof
VA Medical Center, Boston   
Dir Coop Studies Program

Vanderbilt University
Research Associate Professor

Vertex Pharmaceuticals Inc   
Sr. Research Fellow

As part of the Molecular Med TRI-CON 2012, attendees have access to 2 partnering forums, 5 symposia, 18 short courses, and 12 core programs. The event attracts than 3,000 attendees and provides attendees an opportunity to interact with each other in the shared exhibit/poster hall, plenary keynotes and social functions.

Advance registration discounts are available until January 13, 2012. To view the entire Informatics conference agenda and to register, please visit http://www.TriConference.com/IRD

To inquire about sponsoring and/or exhibiting, contact Jon Stroup, 781-972-5483, jstroup@healthtech.com.

Writers and editors are encouraged to attend. To request a press pass, contact Tracey Fielding at tfielding@healthtech.com.

About Cambridge Healthtech Institute (www.chicorporate.com)

Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations. CHI’s portfolio of products includes Cambridge Healthtech Institute Conferences, Insight Pharma Reports, Barnett International, Cambridge Marketing Consultants, Cambridge Meeting Planners and Cambridge Healthtech’s Media Group, which includes numerous e-newsletters as well as Bio-IT World magazine.

Founded in 1992, Cambridge Healthtech Institute strives to develop quality information sources that provide valuable new insights and competing points of view while offering balanced coverage of the latest developments. Basic research related to commercial implications is covered, with heavy emphasis placed on end-user insights into new products and technology as well as coverage on the strategy behind the business.

Contact:
James Prudhomme
Cambridge Healthtech Institute
781-972-5400
jprudhomme@healthtech.com